sertraline has been researched along with Anankastic Personality in 172 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (0.58) | 18.7374 |
1990's | 54 (31.40) | 18.2507 |
2000's | 63 (36.63) | 29.6817 |
2010's | 41 (23.84) | 24.3611 |
2020's | 13 (7.56) | 2.80 |
Authors | Studies |
---|---|
Betcher, H; Pease, E; Singh, B; Ziegelmann, M | 1 |
Askari, S; Mokhtari, S; Shalbafan, M; Shariat, SV; Shariati, B; Yarahmadi, M | 1 |
Deng, F; Fu, X; Huang, L; Li, H; Li, L; Tang, X; Tao, Y; Wang, X; Wang, Y; Xu, H; Yin, L; Zhang, H; Zou, S | 1 |
Antony, G; Banaschewski, T; Briegel, W; Correll, CU; Egberts, KM; Fekete, S; Fleischhaker, C; Gerlach, M; Hellenschmidt, T; Heuschmann, P; Imgart, H; Kaess, M; Karwautz, A; Kölch, M; Malzahn, U; Plener, PL; Reitzle, K; Renner, T; Reuter-Dang, SY; Rexroth, C; Rock, H; Romanos, M; Scherf-Clavel, M; Schulte-Körne, G; Smigielski, L; Taurines, R; Theisen, F; Tini, E; Unterecker, S; Walitza, S; Wewetzer, C | 1 |
Baniasadipour, H; Mowla, A | 1 |
Eftekhar Ardebili, M; Ghobadian, A; Kamalzadeh, L; Mokhtari, S; Shalbafan, M; Shariati, B; Shati, M; Yarahmadi, M | 1 |
Cui, Z; Gong, W; Li, J; Lu, Y; Zhang, F | 1 |
Calarge, CA | 1 |
Askari, S; Eissazade, N; Shalbafan, M; Shariat, SV; Shariati, B; Shokrani, M; Yarahmadi, M | 1 |
Preskorn, SH; Rode, R | 1 |
Freidl, M; Velikić, V; Wippel, A | 1 |
Imperato, JS; Jin, YO; Li, JZ; Pappadopulos, EA; Si, T; Wang, G; Yan, L; Yang, L; Yu, W; Zou, KH | 1 |
Behler, N; Hasan, A; Kirsch, B; Kumpf, U; Leitner, B; Padberg, F; Palm, U; Wulf, L | 1 |
Dastgheib, SA; Modarresi, F; Mowla, A | 1 |
Nair, A; O'Gorman, B; O'Kearney, R; Turner, C | 1 |
Ahmad, J; Gupta, B; Kar, SK; Shrivastava, A | 1 |
Barsoum, A; Benkelfat, C; Berney, A; Cottraux, J; Diksic, M; Gravel, P; Leyton, M; Lissemore, JI; Nordahl, TE; Pinard, G; Sibon, I; Sookman, D | 1 |
de Koning, PP; Denys, D; van Bennekom, MJ | 1 |
Akaho, R; Deguchi, I; Kigawa, H; Nishimura, K | 1 |
Dahl, K; Haugland, BS; Hybel, KA; Højgaard, DRMA; Ivarsson, T; Jensen, S; Melin, K; Nissen, JB; Skarphedinsson, G; Skärsäter, I; Thomsen, PH; Torp, NC; Valderhaug, R; Weidle, B | 1 |
Bernstein, GA; Carstedt, PA; Conelea, CA; Cullen, KR; Harris, EC; Lee, SS; Mueller, BA; Zagoloff, AD | 1 |
Via, E | 1 |
Avci, A; Erken, E; Gul Celik, G; Ray, PC; Tas, DA; Yolga Tahiroglu, A | 1 |
Bussing, R; Geffken, GR; Mason, DM; McNamara, JP; Meyer, JM; Murphy, TK; Reid, AM; Storch, EA | 1 |
Bustillo, JR; Lemke, NT | 1 |
Andreou, C; Giegling, I; Hegerl, U; Juckel, G; Leicht, G; Mavrogiorgou, P; Mulert, C; Pogarell, O; Popescu, V; Rujescu, D; Zaudig, M | 1 |
Bussing, R; Garvan, CS; Geffken, GR; Goodman, WK; Lewin, AB; McNamara, JP; Murphy, TK; Rahman, O; Small, BJ; Storch, EA | 1 |
Brezinka, V; Grünblatt, E; Tschakarjan, S; Walitza, S | 1 |
Amerio, A; Ghaemi, SN; Marchesi, C; Odone, A | 1 |
Compton, SN; Dahl, K; Hybel, K; Ivarsson, T; Melin, KH; Nissen, JB; Skarphedinsson, G; Thomsen, PH; Torp, NC; Valderhaug, R; Weidle, B; Wentzel-Larsen, T | 1 |
Aydın, K; Barburoğlu, M; Ertekin, E; Özyıldırım, SŞ; Tükel, R | 1 |
Brissos, S; Gama-Marques, J; Jesus, G | 1 |
King, AL; Nardi, AE; Santos, V | 1 |
Compton, S; Dahl, K; Hybel, K; Ivarsson, T; Melin, KH; Nissen, JB; Skarphedinsson, G; Thomsen, PH; Torp, NC; Valderhaug, R; Weidle, B; Wentzel-Larsen, T | 1 |
Hoyte, CO; Srisuma, S; Wanaukul, W; Wongvisavakorn, S | 1 |
Patterson, B; Van Ameringen, M | 1 |
Ivarsson, T; Skarphedinsson, G; Weidle, B | 1 |
Matheiken, S | 1 |
Bussing, R; Geffken, GR; Goodman, WK; Guzick, AG; McNamara, JP; Murphy, TK; Reid, AM; Storch, EA | 1 |
Belhaj, A; Ben Youssef, H; Bouasker, A; Bouden, A; Ghachem, R; Halayem, S; Othman, S; Tabbane, K | 1 |
Boostani, S; Dastgheib, SA; Mowla, A | 1 |
Cavanna, AE; Robertson, MM | 1 |
Vitiello, B | 1 |
Geffken, GR; Goldstein, RB; Goodman, WK; Lehmkuhl, H; Murphy, TK; Storch, EA | 1 |
Mendhekar, DN | 1 |
Ros, LT | 3 |
Moretti, M | 1 |
Grzesiak, M; Pacan, P; Reich, A; Szepietowski, JC | 1 |
Aigner, M; Asenbaum, S; Hornik, K; Pirker, W; Ritter, K; Stompe, T; Thau, K; Zettinig, G; Zitterl, W; Zitterl-Eglseer, K | 1 |
Allgair, A; Flessner, CA; Foa, E; Franklin, ME; Freeman, J; Garcia, A; March, J; Sapyta, J | 1 |
Gilbert, AR; Maalouf, FT | 1 |
Bär, KJ; Gohle, D; Hegerl, U; Juckel, G; Mavorgiorgou, P; Mulert, C; Pogarell, O; Rujescu, D; Winter, C; Zaudig, M | 1 |
Bogetto, F; Chiadò Piat, S; Maina, G; Rigardetto, S; Rosso, G | 1 |
Malinina, EV; Zabozlaeva, IV | 1 |
Foa, EB; Franklin, ME; Freeman, JB; Garcia, AM; March, JS; Moore, PS; Sapyta, JJ | 1 |
Borges, CP; Cordioli, AV; Ferrão, YA; Meyer, E; Sousa, MB; Souza, FP | 1 |
Gentile, S | 1 |
Foa, EB; Franklin, ME; Freeman, J; Garcia, A; March, JS; Przeworski, A; Zoellner, LA | 1 |
Cavanna, AE; Rickards, H; Worrall, R | 1 |
Bussing, R; Garvan, CW; Goodman, WK; McNamara, JP; Murphy, TK; Reid, AM; Storch, EA | 1 |
Goriunov, AV; Lobacheva, MV | 1 |
Aalouane, R; Rharrabti, S | 1 |
Brüne, M; Patzold, T | 1 |
Arnold, DH | 1 |
Francobandiera, G | 1 |
Kurs, R; Poyurovsky, M; Weizman, A | 1 |
Bhattacharyya, S; Girishchandra, BG; Khanna, S | 1 |
Chung, H; Cook, EH; Messig, M; Wagner, KD | 1 |
Hegerl, U; Juckel, G; Mavrogiorgou, P; Mergl, R; Zaudig, M | 2 |
Gal, G; Goshen, E; Hendler, T; Sasson, Y; Tzila Zwas, S; Zohar, J | 1 |
Broocks, A; Hohagen, F; Kordon, A | 1 |
Göbel, C; Hegerl, U; Juckel, G; Mavrogiorgou, P; Mergl, R; Vogel, M; Zaudig, M | 1 |
Albert, U; Bogetto, F; Maina, G; Salvi, V | 1 |
Asbahr, FR; Castillo, AR; Ito, LM; Latorre, MR; Lotufo-Neto, F; Moreira, MN | 1 |
Likasitwattanakul, S | 1 |
Austin, C; Crits-Christoph, P; Davidson, JR; Kiev, A; Koran, LM; Mandel, FS; Ninan, PT; Rasmussen, SA; Robinson, DG; Zajecka, JM | 1 |
Denys, D | 1 |
Cordioli, AV; Isolan, LR; Manfro, GG; Oliveira, RR; Sousa, MB | 1 |
Bailly, D | 1 |
Antonio, C; Maurizio, B; Silvia, M | 1 |
Barbe, R; Baumann, P; Crettol, S; Eap, CB; Garran, E; Vabre-Bogdalova, A | 1 |
Foa, E; Franklin, ME; Freeman, J; Garcia, A; Leonard, H; March, JS; Moore, P | 1 |
Fernandez, HH; Nguyen, FN; Okun, MS; Pauly, RR | 1 |
Geffken, GR; Lehmkuhl, H; Murphy, TK; Storch, EA; Touchton, A | 1 |
Coffey, B; Kotcher, L; Wieland, N | 1 |
O'Kearney, R | 1 |
Bonnot, O; Cohen, D; Warot, D | 1 |
Fineberg, NA; Ipser, J; Pallanti, S; Pampaloni, I; Stein, DJ | 1 |
Busto, G; Di Spigno, D; Falcini, R; Salvati, L; Tundo, A | 1 |
Ghanizadeh, A | 1 |
Podgórski, JK; Roś, LT | 1 |
Corrêa, H; Lage, NV; Rocha, FF | 1 |
Oner, O; Oner, P | 1 |
Ağargün, MY; Aşkin, R; Aydin, A; Beşiroğlu, L; Uğuz, F; Yilmaz, E | 1 |
Akman, C; Cilli, AS; Kaya, N; Sahingoz, M; Uguz, F | 1 |
Koran, LM; Thienemann, M | 1 |
Menkes, DB | 1 |
Chouinard, G; DuBoff, E; Greist, JH; Halaris, A; Jefferson, JW; Kim, SW; Kobak, KA; Koran, L; Liebowtiz, MR; Lydiard, B | 1 |
Chouinard, G; DuBoff, E; Greist, J; Halaris, A; Kim, SW; Koran, L; Liebowitz, M; Lydiard, RB; Rasmussen, S; White, K | 1 |
Bellantuono, C; Piccinelli, M; Pini, S; Wilkinson, G | 1 |
Greist, JH; Jefferson, JW; Katzelnick, DJ; Kobak, KA; Serlin, RC | 1 |
Lydiard, RB | 1 |
Calamari, JE; Faber, SD; Hitsman, BL; Poppe, CJ | 1 |
Deltito, JA | 1 |
Allen, L; Tejera, C | 1 |
Jackson, CW; Lydiard, RB; Morton, WA | 1 |
Zinner, SH | 1 |
Bakish, D; Joffe, RT | 1 |
Hollander, E; Josephson, SC; Stein, DJ | 1 |
Lamberti, JS; Wiener, K | 1 |
Goodman, WK; McDougle, CJ; Price, LH | 2 |
Cole, JO; Kando, JC; Tohen, M; Weiss, MK; Zarate, CA | 1 |
Gilman, D; Hayden, CT; Kalivas, J; Kalivas, L | 1 |
Rush, AJ; Suppes, T | 1 |
Byerly, MJ; Christensen, R; Goodman, WK | 1 |
Koran, LM; Maloney, A; Mueller, K | 1 |
Carpenter, LL; Epperson, CN; McDougle, CJ; Price, LH | 1 |
Beach, K; Nesbitt, L; Richman, H; Sallee, FR; Sethuraman, G | 1 |
Labbate, LA; Oleshansky, MA | 1 |
Olivera, AO | 1 |
Byerly, MJ; Christensen, RC; Cuadros, C; Dodt, JE | 1 |
Bouwer, C; Stein, DJ; van Heerden, B | 1 |
Dryden-Edwards, RC; Reiss, AL | 1 |
Brenner, EM; King, RA; Lynch, KA; Scahill, L; Vitulano, LA | 1 |
Anand, A; Barr, LC; Goodman, WK; McDougle, CJ; Price, LH | 1 |
Bisserbe, JC; Flament, MF | 1 |
Atala, KD; Baer, L; Beer, DA; Eisen, JL; Phillips, KA; Rasmussen, SA | 1 |
DuBoff, E; Greist, J; Hackett, E; Halaris, A; Koran, LM; Liebowitz, M; Lydiard, RB; McElroy, S; Mendels, J; O'Connor, K; Rasmussen, S | 1 |
Alderman, J; Chung, M; Johnston, HF; Wolkow, R | 1 |
Grace, JJ; Pato, MT; Priest, B; Rahman, MS | 1 |
Biederman, J; Cook, EH; Cutler, NR; Dominguez, R; Ferguson, J; March, JS; Mardekian, J; Muller, B; Riesenberg, R; Rosenthal, M; Safferman, A; Sallee, FR; Steiner, H; Wagner, KD; Wolkow, R | 1 |
Benazzi, F | 1 |
Clary, CM | 1 |
Apter, J; Asnis, G; Bystritsky, A; Curtis, G; Du Pont, IJ; Ferguson, J; Kronig, MH; Landbloom, R; Munjack, D; Phillips, K; Riesenberg, R; Robinson, D; Roy-Byrne, P | 1 |
Biederman, J; Faraone, SV; Fine, CS; Geller, D; March, JS; Millstein, RB; Spencer, TJ; Wilens, TE; Wolkow, R | 1 |
Lee, CD; Lee, DO | 1 |
Couturier, J; Steele, M | 1 |
Marazziti, D; Pallanti, S | 1 |
Black, DW; Chapman, D; Clary, C; Greist, JH; Harrison, W; Hoehn-Saric, R; Lydiard, B; McElroy, S; Ninan, P; Stahl, S; Zajecka, J | 1 |
Borgeat, F; Freeston, MH; Todorov, C | 1 |
Khanna, S; Kumar, TC | 1 |
Khanna, S; Kumar, TC; Raju, GV | 1 |
Hirschfeld, RM | 1 |
Kashnikova, AA; Kim, LV; Koren', EV; Tatarova, IN; Voloshina, VM | 1 |
Goldstein, A; Munera, PA | 1 |
Biederman, J; Cook, EH; Landau, P; March, JS; Messig, M; Wagner, KD; Wolkow, R | 1 |
Rabe-Jabłońska, J | 1 |
Greenberg, BD; Hoehn-Saric, R; McLeod, DR; Pearlson, GD; Schlaepfer, TE; Wong, SH | 1 |
Kane, JM | 1 |
Hackett, E; Koran, LM; Robinson, D; Rubin, A; Wolkow, R | 1 |
Carmin, CN; Gillock, KL; Wiegartz, PS; Yunus, U | 1 |
Austin, C; Bergeron, R; Chaput, Y; Goldner, E; Hadrava, V; Ravindran, AV; Swinson, R; van Ameringen, MA | 1 |
Albert, U; Bogetto, F; Maina, G | 1 |
McTavish, D; Murdoch, D | 1 |
Kriete, M; Rapoport, JL; Ryland, DH | 1 |
Chouinard, G | 1 |
Bullock, T; Fineberg, N; Montgomery, D; Montgomery, SA | 1 |
Berman, H; Salzman, C; Sapers, BL | 1 |
Bullock, T; Fineberg, NA; Montgomery, DB; Montgomery, SA | 1 |
Guthrie, SK | 1 |
Baer, L; Buttolph, L; Holland, A; Hyman, S; Jenike, MA; Minichiello, WE; Ricciardi, J; Seymour, R; Summergrad, P | 1 |
Baer, L; Holland, A; Jenike, MA; Minichiello, WE; Seymour, R; Summergrad, P | 1 |
Bick, PA; Chouinard, G; Gaffney, M; Goodman, W; Greist, J; Hackett, E; Jenike, M; Rasmussen, S; White, K | 1 |
Heym, J; Koe, BK | 1 |
30 review(s) available for sertraline and Anankastic Personality
Article | Year |
---|---|
Comparing the efficacy of pharmacological and psychological treatment, alone and in combination, in children and adolescents with obsessive-compulsive disorder: A network meta-analysis.
Topics: Adolescent; Child; Cognitive Behavioral Therapy; Humans; Network Meta-Analysis; Obsessive-Compulsive Disorder; Sertraline; Treatment Outcome | 2022 |
Prefrontal tDCS and sertraline in obsessive compulsive disorder: a case report and review of the literature.
Topics: Adult; Humans; Longitudinal Studies; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Transcranial Direct Current Stimulation | 2017 |
Moderators and predictors of response to cognitive behaviour therapy for pediatric obsessive-compulsive disorder: A systematic review.
Topics: Adolescent; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Obsessive-Compulsive Disorder; Predictive Value of Tests; Randomized Controlled Trials as Topic; Sertraline; Tic Disorders; Treatment Outcome | 2018 |
Obsessive-Compulsive Disorder Following Cerebrovascular Accident: A Case Report and Literature Review.
Topics: Cerebral Angiography; Cerebrovascular Circulation; Endovascular Procedures; Humans; Infarction, Middle Cerebral Artery; Magnetic Resonance Angiography; Male; Mental Status and Dementia Tests; Middle Aged; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Stents; Thrombolytic Therapy; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2019 |
The disaster was my fault!
Topics: Adolescent; Child; Child, Preschool; Compulsive Behavior; Ego; Humans; Internal-External Control; Longitudinal Studies; Male; Neuropsychological Tests; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Self Concept; September 11 Terrorist Attacks; Sertraline; Tourette Syndrome; Treatment Outcome | 2007 |
[Trichotillomania and comorbidity--lamotrigine in a new perspective].
Topics: Adolescent; Adult; Antidepressive Agents; Antimanic Agents; Anxiety; Behavior, Addictive; Bipolar Disorder; Child; Child Abuse; Comorbidity; Compulsive Behavior; Cyclothymic Disorder; Drug Therapy, Combination; Female; Humans; Impulsive Behavior; Lamotrigine; Magnetic Resonance Imaging; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Spouse Abuse; Stress Disorders, Post-Traumatic; Treatment Outcome; Triazines; Trichotillomania | 2008 |
Efficacy of antidepressant medications in children and adolescents with obsessive-compulsive disorder: a systematic appraisal.
Topics: Adolescent; Antidepressive Agents; Child; Clomipramine; Humans; Obsessive-Compulsive Disorder; Research Design; Sertraline; Time Factors; Treatment Outcome | 2011 |
[Obsessive-compulsive disorders in general practice. How the obsessive-compulsive neurotic is revealed by skin and hair].
Topics: Adolescent; Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior Therapy; Child; Citalopram; Clomipramine; Depression; Diagnosis, Differential; Eczema; Family Practice; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Psychotherapy; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires; Time Factors; Trichotillomania | 2003 |
Pharmacotherapy of obsessive-compulsive disorder and obsessive-compulsive spectrum disorders.
Topics: Brain; Clomipramine; Cognitive Behavioral Therapy; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Positron-Emission Tomography; Selective Serotonin Reuptake Inhibitors; Sertraline | 2006 |
[Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents].
Topics: Adolescent; Adult; Age Factors; Antidepressive Agents, Second-Generation; Case-Control Studies; Child, Preschool; Citalopram; Confidence Intervals; Depressive Disorder; Family Practice; Female; Fluoxetine; Fluvoxamine; History, Medieval; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Placebos; Psychotherapy; Randomized Controlled Trials as Topic; Risk; Safety; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Sertraline; Suicide; Suicide, Attempted | 2006 |
Differences in generic sertraline for children: real or artefact from cost containing to clinical quality of generics use.
Topics: Antidepressive Agents; Child; Child Health Services; Cost-Benefit Analysis; Depressive Disorder, Major; Drugs, Generic; Humans; Obsessive-Compulsive Disorder; Quality Assurance, Health Care; Sertraline | 2006 |
Benefits of cognitive-behavioural therapy for children and youth with obsessive-compulsive disorder: re-examination of the evidence.
Topics: Adolescent; Anti-Anxiety Agents; Child; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Fluvoxamine; Follow-Up Studies; Humans; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Sertraline; Treatment Outcome | 2007 |
Sustained response versus relapse: the pharmacotherapeutic goal for obsessive-compulsive disorder.
Topics: Clomipramine; Fluoxetine; Humans; Meta-Analysis as Topic; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2007 |
Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
Topics: 1-Naphthylamine; Adolescent; Adult; Antidepressive Agents; Child; Clomipramine; Double-Blind Method; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Placebos; Sertraline; Treatment Outcome | 1995 |
Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis.
Topics: 1-Naphthylamine; Adolescent; Adult; Clomipramine; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Multicenter Studies as Topic; Obsessive-Compulsive Disorder; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1995 |
Obsessive-compulsive disorder: a new perspective in diagnosis and treatment.
Topics: 1-Naphthylamine; Humans; Multicenter Studies as Topic; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
Treatment of obsessive compulsive disorder in the elderly: a review and case example.
Topics: 1-Naphthylamine; Aged; Aged, 80 and over; Behavior Therapy; Combined Modality Therapy; Desensitization, Psychologic; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
The pharmacotherapy of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Buspirone; Clomipramine; Desipramine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline | 1993 |
Does intolerance or lack of response with fluoxetine predict the same will happen with sertraline?
Topics: 1-Naphthylamine; Adolescent; Adult; Bipolar Disorder; Depressive Disorder; Drug Tolerance; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Adult; Aged; Antidepressive Agents; Buspirone; Child; Clomipramine; Clonazepam; Costs and Cost Analysis; Dopamine Antagonists; Drug Interactions; Drug Tolerance; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Lithium; Obsessive-Compulsive Disorder; Paroxetine; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Tryptophan | 1996 |
Pharmacologic treatment of obsessive-compulsive disorder: comparative studies.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Clinical Trials as Topic; Clomipramine; Fluoxetine; Fluvoxamine; Humans; Meta-Analysis as Topic; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1997 |
On the pharmacotherapy of obsessive-compulsive disorder: is a consensus possible?
Topics: Clomipramine; Double-Blind Method; Expert Testimony; Fluoxetine; Fluvoxamine; Guidelines as Topic; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2000 |
Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Animals; Binding Sites; Brain; Depression; Drug Tolerance; Electroencephalography; Humans; Obsessive-Compulsive Disorder; Psychomotor Performance; Rats; Receptors, Neurotransmitter; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline | 1992 |
Sertraline in the treatment of obsessive compulsive disorder: two double-blind, placebo-controlled studies.
Topics: 1-Naphthylamine; Clomipramine; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline | 1992 |
Sertraline: a new serotonergic antidepressant.
Topics: 1-Naphthylamine; Animals; Depressive Disorder; Humans; Obsessive-Compulsive Disorder; Sertraline | 1992 |
Serotonin reuptake inhibitors are the treatment of choice in obsessive compulsive disorder.
Topics: 1-Naphthylamine; Behavior Therapy; Clomipramine; Combined Modality Therapy; Depressive Disorder; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Serotonin Antagonists; Sertraline | 1992 |
Pharmacotherapy of obsessive compulsive disorder.
Topics: 1-Naphthylamine; Antidepressive Agents; Clomipramine; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Neurotransmitter Uptake Inhibitors; Obsessive-Compulsive Disorder; Paroxetine; Piperidines; Serotonin; Sertraline | 1992 |
Sertraline: a new specific serotonin reuptake blocker.
Topics: 1-Naphthylamine; Aged; Alcohol Drinking; Animals; Appetite; Clinical Trials as Topic; Depression; Down-Regulation; Drug Interactions; Humans; Middle Aged; Obsessive-Compulsive Disorder; Psychomotor Performance; Serotonin Antagonists; Sertraline | 1991 |
A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
Topics: 1-Naphthylamine; Adult; Ambulatory Care; Clinical Trials as Topic; Clomipramine; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Meta-Analysis as Topic; Obsessive-Compulsive Disorder; Oximes; Placebos; Psychiatric Status Rating Scales; Serotonin; Serotonin Antagonists; Sertraline | 1990 |
Pharmacology of sertraline: a review.
Topics: 1-Naphthylamine; Animals; Behavior, Animal; Body Weight; Depressive Disorder; Humans; Naphthalenes; Obsessive-Compulsive Disorder; Rats; Serotonin Antagonists; Sertraline | 1988 |
54 trial(s) available for sertraline and Anankastic Personality
Article | Year |
---|---|
Memantine augmentation of sertraline in the treatment of symptoms and executive function among patients with obsessive-compulsive disorder: A double-blind placebo-controlled, randomized clinical trial.
Topics: Double-Blind Method; Drug Therapy, Combination; Executive Function; Humans; Iran; Memantine; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2022 |
Is mirtazapine augmentation effective for patients with obsessive-compulsive disorder who failed to respond to sertraline monotherapy? A placebo-controlled, double-blind, clinical trial.
Topics: Humans; Mirtazapine; Obsessive-Compulsive Disorder; Sertraline | 2023 |
Granisetron-mediated augmentation of sertraline therapeutic effect in obsessive-compulsive disorder: a double-blind placebo-controlled, randomized clinical trial.
Topics: Double-Blind Method; Drug Therapy, Combination; Granisetron; Humans; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Treatment Outcome | 2022 |
Agomelatine augmentation of sertraline in the treatment of moderate to severe obsessive-compulsive disorder: a randomized double-blinded placebo-controlled clinical trial.
Topics: Acetamides; Drug-Related Side Effects and Adverse Reactions; Humans; Iran; Obsessive-Compulsive Disorder; Sertraline | 2023 |
Comparing escitaloipram with sertraline for obsessive and compulsive symptoms in patients with obsessive compulsive disorder: A comparative double blind clinical trial.
Topics: Adult; Citalopram; Double-Blind Method; Female; Humans; Male; Obsessive-Compulsive Disorder; Outcome Assessment, Health Care; Selective Serotonin Reuptake Inhibitors; Sertraline; Young Adult | 2018 |
Brain serotonin synthesis capacity in obsessive-compulsive disorder: effects of cognitive behavioral therapy and sertraline.
Topics: Adult; Brain; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Positron-Emission Tomography; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Treatment Outcome; Young Adult | 2018 |
Treatment Gains Are Sustainable in Pediatric Obsessive-Compulsive Disorder: Three-Year Follow-Up From the NordLOTS.
Topics: Adolescent; Child; Cognitive Behavioral Therapy; Follow-Up Studies; Humans; Obsessive-Compulsive Disorder; Sertraline; Treatment Outcome | 2020 |
Sertraline Effects on Striatal Resting-State Functional Connectivity in Youth With Obsessive-Compulsive Disorder: A Pilot Study.
Topics: Adolescent; Brain Mapping; Case-Control Studies; Child; Corpus Striatum; Female; Humans; Magnetic Resonance Imaging; Male; Neural Pathways; Obsessive-Compulsive Disorder; Pilot Projects; Sertraline | 2019 |
Prospective relationship between obsessive-compulsive and depressive symptoms during multimodal treatment in pediatric obsessive-compulsive disorder.
Topics: Adolescent; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Compulsive Behavior; Depression; Female; Humans; Male; Obsessive Behavior; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Symptom Assessment | 2014 |
Randomized, placebo-controlled trial of cognitive-behavioral therapy alone or combined with sertraline in the treatment of pediatric obsessive-compulsive disorder.
Topics: Adolescent; Antidepressive Agents; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Humans; Male; Obsessive-Compulsive Disorder; Patient Compliance; Sertraline; Treatment Outcome | 2013 |
Continued cognitive-behavior therapy versus sertraline for children and adolescents with obsessive-compulsive disorder that were non-responders to cognitive-behavior therapy: a randomized controlled trial.
Topics: Adolescent; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Denmark; Female; Humans; Male; Norway; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Sweden; Treatment Outcome | 2015 |
Tics Moderate Sertraline, but Not Cognitive-Behavior Therapy Response in Pediatric Obsessive-Compulsive Disorder Patients Who Do Not Respond to Cognitive-Behavior Therapy.
Topics: Adolescent; Child; Cognitive Behavioral Therapy; Humans; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Tic Disorders; Treatment Outcome | 2015 |
Sertraline Treatment of Nonresponders to Extended Cognitive-Behavior Therapy in Pediatric Obsessive-Compulsive Disorder.
Topics: Adolescent; Child; Cognitive Behavioral Therapy; Female; Humans; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Failure | 2015 |
Side-effects of SSRIs disrupt multimodal treatment for pediatric OCD in a randomized-controlled trial.
Topics: Adolescent; Akathisia, Drug-Induced; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Double-Blind Method; Emotions; Female; Humans; Inhibition, Psychological; Male; Models, Statistical; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2015 |
Duloxetine Augmentation in Resistant Obsessive-Compulsive Disorder: A Double-Blind Controlled Clinical Trial.
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Treatment Outcome; Young Adult | 2016 |
The impact of neuropsychological functioning on treatment outcome in pediatric obsessive-compulsive disorder.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Child; Cognition Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Executive Function; Female; Humans; Male; Mental Recall; Neuropsychological Tests; Obsessive-Compulsive Disorder; Psychomotor Performance; Sertraline; Wechsler Scales | 2010 |
No effect of adding brief dynamic therapy to pharmacotherapy in the treatment of obsessive-compulsive disorder with concurrent major depression.
Topics: Adult; Combined Modality Therapy; Depressive Disorder, Major; Female; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Psychotherapy, Brief; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2010 |
Predictors and moderators of treatment outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I).
Topics: Adolescent; Awareness; Child; Codependency, Psychological; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Disability Evaluation; Female; Humans; Internal-External Control; Linear Models; Male; Obsessive-Compulsive Disorder; Parent-Child Relations; Prognosis; Selective Serotonin Reuptake Inhibitors; Sertraline | 2010 |
Cognitive-behavioral group therapy versus sertraline for obsessive-compulsive disorder: five-year follow-up.
Topics: Cognitive Behavioral Therapy; Follow-Up Studies; Humans; Obsessive-Compulsive Disorder; Psychotherapy, Group; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors | 2011 |
Maternal and child expressed emotion as predictors of treatment response in pediatric obsessive-compulsive disorder.
Topics: Adolescent; Analysis of Variance; Child; Child Behavior Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Expressed Emotion; Family; Female; Humans; Male; Mother-Child Relations; Mothers; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Self Report; Sertraline | 2012 |
Psychometric properties of the Treatment-Emergent Activation and Suicidality Assessment Profile (TEASAP) in youth with OCD.
Topics: Adolescent; Anxiety; Checklist; Child; Child Behavior; Depression; Female; Humans; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Psychometrics; Psychomotor Agitation; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicidal Ideation | 2013 |
Remission status after long-term sertraline treatment of pediatric obsessive-compulsive disorder.
Topics: Adolescent; Aging; Child; Female; Humans; Long-Term Care; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2003 |
Effects of sertraline on kinematic aspects of hand movements in patients with obsessive-compulsive disorder.
Topics: Adult; Biomechanical Phenomena; Female; Hand; Handwriting; Humans; Male; Motor Skills Disorders; Movement; Movement Disorders; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline | 2004 |
Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.
Topics: Adult; Ambulatory Care; Citalopram; Clomipramine; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Male; Obesity; Obsessive-Compulsive Disorder; Paroxetine; Patient Compliance; Prospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Weight Gain | 2004 |
Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.
Topics: Adolescent; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline | 2004 |
Can a subgroup of OCD patients with motor abnormalities and poor therapeutic response be identified?
Topics: Adult; Behavior Therapy; Biomechanical Phenomena; Combined Modality Therapy; Drug Resistance; Female; Handwriting; Humans; Male; Motor Skills; Movement Disorders; Nervous System Diseases; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Signal Processing, Computer-Assisted | 2005 |
Group cognitive-behavioral therapy versus sertraline for the treatment of children and adolescents with obsessive-compulsive disorder.
Topics: Adolescent; Child; Cognitive Behavioral Therapy; Female; Humans; Male; Obsessive-Compulsive Disorder; Outcome and Process Assessment, Health Care; Psychotherapy, Group; Selective Serotonin Reuptake Inhibitors; Sertraline | 2005 |
High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial.
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Resistance; Female; Humans; Male; Obsessive-Compulsive Disorder; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome | 2006 |
A randomized clinical trial of cognitive-behavioral group therapy and sertraline in the treatment of obsessive-compulsive disorder.
Topics: Adult; Ambulatory Care; Cognitive Behavioral Therapy; Female; Humans; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Psychotherapy, Group; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome | 2006 |
Do soft signs predict treatment outcome in obsessive-compulsive disorder?
Topics: 1-Naphthylamine; Adult; Attention Deficit Disorder with Hyperactivity; Double-Blind Method; Female; Fluvoxamine; Frontal Lobe; Gyrus Cinguli; Humans; Male; Middle Aged; Neuropsychological Tests; Obsessive-Compulsive Disorder; Prognosis; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1995 |
A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Obsessive-Compulsive Disorder; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline | 1995 |
Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Adult; Ambulatory Care; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Monitoring; Female; Humans; Male; Obsessive-Compulsive Disorder; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline | 1995 |
Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
Topics: 1-Naphthylamine; Adolescent; Adult; Antidepressive Agents; Child; Clomipramine; Double-Blind Method; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Placebos; Sertraline; Treatment Outcome | 1995 |
Combined SSRI-moclobemide treatment of psychiatric illness.
Topics: 1-Naphthylamine; Adult; Benzamides; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Male; Mental Disorders; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Obsessive-Compulsive Disorder; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
Platelet serotonin transporter in children and adolescents with obsessive-compulsive disorder or Tourette's syndrome.
Topics: 1-Naphthylamine; Adolescent; Analysis of Variance; Blood Platelets; Carrier Proteins; Child; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sertraline; Tourette Syndrome | 1996 |
Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Adrenergic Uptake Inhibitors; Adult; Clomipramine; Desipramine; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1997 |
The Brown Assessment of Beliefs Scale: reliability and validity.
Topics: 1-Naphthylamine; Adult; Affective Disorders, Psychotic; Awareness; Brief Psychiatric Rating Scale; Delusions; Factor Analysis, Statistical; Female; Humans; Male; Mental Disorders; Obsessive-Compulsive Disorder; Personality Inventory; Prognosis; Psychiatric Status Rating Scales; Psychometrics; Reproducibility of Results; Sensitivity and Specificity; Sertraline; Severity of Illness Index; Somatoform Disorders; Tape Recording; Treatment Outcome | 1998 |
A 2-year study of sertraline in the treatment of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Adult; Aged; Dizziness; Double-Blind Method; Female; Headache; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Initiation and Maintenance Disorders | 1997 |
Sertraline treatment of children and adolescents with obsessive-compulsive disorder or depression: pharmacokinetics, tolerability, and efficacy.
Topics: 1-Naphthylamine; Adolescent; Age Factors; Analysis of Variance; Child; Depressive Disorder; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial.
Topics: Adolescent; Antidepressive Agents; Child; Double-Blind Method; Female; Humans; Male; Obsessive-Compulsive Disorder; Psychological Tests; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1998 |
Placebo-controlled, multicenter study of sertraline treatment for obsessive-compulsive disorder.
Topics: Adult; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Sertraline | 1999 |
Absence of cardiovascular adverse effects of sertraline in children and adolescents.
Topics: Adolescent; Antidepressive Agents; Blood Pressure; Child; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Hemodynamics; Humans; Male; Obsessive-Compulsive Disorder; Sertraline | 1999 |
Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Tricyclic; Comorbidity; Depressive Disorder; Desipramine; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2000 |
On the pharmacotherapy of obsessive-compulsive disorder: is a consensus possible?
Topics: Clomipramine; Double-Blind Method; Expert Testimony; Fluoxetine; Fluvoxamine; Guidelines as Topic; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2000 |
Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder.
Topics: Adolescent; Child; Consumer Product Safety; Female; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors | 2001 |
Cerebral blood flow in obsessive-compulsive patients with major depression: effect of treatment with sertraline or desipramine on treatment responders and non-responders.
Topics: Adult; Aged; Blood Flow Velocity; Cerebral Cortex; Depressive Disorder, Major; Desipramine; Dominance, Cerebral; Double-Blind Method; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Obsessive-Compulsive Disorder; Regional Blood Flow; Sertraline; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2001 |
Efficacy of sertraline in the long-term treatment of obsessive-compulsive disorder.
Topics: Adolescent; Adult; Double-Blind Method; Female; Follow-Up Studies; Humans; Long-Term Care; Male; Obsessive-Compulsive Disorder; Patient Dropouts; Quality of Life; Recurrence; Sertraline; Single-Blind Method; Treatment Outcome | 2002 |
Sertraline and fluoxetine treatment of obsessive-compulsive disorder: results of a double-blind, 6-month treatment study.
Topics: Adolescent; Adult; Female; Fluoxetine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2002 |
Sertraline treatment of obsessive-compulsive disorder: efficacy and tolerability of a rapid titration regimen.
Topics: Analysis of Variance; Antidepressive Agents; Chi-Square Distribution; Drug Administration Schedule; Female; Humans; Male; Obsessive-Compulsive Disorder; Sertraline; Single-Blind Method | 2002 |
Drug treatment of canine acral lick. An animal model of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Animals; Clomipramine; Dermatitis; Desipramine; Disease Models, Animal; Dog Diseases; Dogs; Double-Blind Method; Fenfluramine; Fluoxetine; Follow-Up Studies; Grooming; Humans; Neurotransmitter Uptake Inhibitors; Obsessive-Compulsive Disorder; Serotonin; Sertraline; Ulcer | 1992 |
Sertraline in the treatment of obsessive compulsive disorder: two double-blind, placebo-controlled studies.
Topics: 1-Naphthylamine; Clomipramine; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline | 1992 |
A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
Topics: 1-Naphthylamine; Adult; Ambulatory Care; Clinical Trials as Topic; Clomipramine; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Meta-Analysis as Topic; Obsessive-Compulsive Disorder; Oximes; Placebos; Psychiatric Status Rating Scales; Serotonin; Serotonin Antagonists; Sertraline | 1990 |
Sertraline in obsessive-compulsive disorder: a double-blind comparison with placebo.
Topics: 1-Naphthylamine; Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Naphthalenes; Obsessive-Compulsive Disorder; Placebos; Serotonin; Serotonin Antagonists; Sertraline | 1990 |
Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Adult; Double-Blind Method; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Serotonin Antagonists; Sertraline | 1990 |
92 other study(ies) available for sertraline and Anankastic Personality
Article | Year |
---|---|
Dose-Dependent Urinary Incontinence with Sertraline Use in Obsessive-Compulsive Disorder.
Topics: Dose-Response Relationship, Drug; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Urinary Incontinence | 2021 |
Therapeutic drug monitoring of sertraline in children and adolescents: A naturalistic study with insights into the clinical response and treatment of obsessive-compulsive disorder.
Topics: Adolescent; Child; Drug Monitoring; Humans; Obsessive-Compulsive Disorder; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 2022 |
Rhabdomyolysis in a male adolescent associated with monotherapy of fluvoxamine.
Topics: Adolescent; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Rhabdomyolysis; Sertraline | 2023 |
Re: "Effects of Long-Term Sertraline Use on Pediatric Growth and Development: The Sertraline Pediatric Registry for The Evaluation of Safety (SPRITES)" by Kolitsopoulos et al.
Topics: Child; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2023 |
Personalized Medicine in the Treatment of a Patient With Obsessive-Compulsive Disorder With Clomipramine.
Topics: Clomipramine; Humans; Obsessive-Compulsive Disorder; Precision Medicine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2023 |
Relapse of obsessive-compulsive disorder after cerebral venous sinus thrombosis: a case report.
Topics: Adolescent; Adult; Clomipramine; Female; Humans; Obsessive-Compulsive Disorder; Recurrence; Sertraline; Sinus Thrombosis, Intracranial | 2020 |
Impact of sertraline daily treatment regimen on adherence, persistence and healthcare resource utilisation in patients with major depressive disorder or obsessive-compulsive disorder: A real-world evidence analysis from the United States.
Topics: Depressive Disorder, Major; Humans; Medication Adherence; Obsessive-Compulsive Disorder; Patient Acceptance of Health Care; Retrospective Studies; Sertraline; United States | 2021 |
Sertraline induced cervical dystonia in a patient of Obsessive Compulsive Disorder.
Topics: Adult; Humans; India; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Torticollis | 2018 |
Social media and smartphone technology in the symptomatology of OCD.
Topics: Adult; Citalopram; Female; Humans; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Smartphone; Social Media | 2018 |
Editorial: Pharmacological Effects on Striatal Resting-State Connectivity in Pediatric Obsessive-Compulsive Disorder: An Opportunity to Modulate Neurodevelopmental Trajectories?
Topics: Adolescent; Child; Corpus Striatum; Humans; Magnetic Resonance Imaging; Obsessive-Compulsive Disorder; Pilot Projects; Sertraline | 2019 |
Periodic fever and hyperimmunoglobulin D syndrome in a boy with pediatric autoimmune neuropsychiatric disorders associated with group A β-Hemolytic streptococcus.
Topics: Attention Deficit Disorder with Hyperactivity; Autoimmune Diseases; Child; Humans; Male; Mevalonate Kinase Deficiency; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Streptococcal Infections; Streptococcus pyogenes; Stuttering; Tourette Syndrome | 2013 |
Clozapine-induced obsessive-compulsive symptoms in bipolar disorder.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Clozapine; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Resistance; Drug Substitution; Drug Therapy, Combination; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Quetiapine Fumarate; Recurrence; Sertraline | 2013 |
P300 in obsessive-compulsive disorder: source localization and the effects of treatment.
Topics: Adolescent; Adult; Antidepressive Agents; Brain Mapping; Case-Control Studies; Cognitive Behavioral Therapy; Electroencephalography; Event-Related Potentials, P300; Female; Frontal Lobe; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Sertraline; Young Adult | 2013 |
Extraordinarily fast response to low-dose sertraline in a child with severe obsessive-compulsive disorder and high functioning serotonin transporter genotype.
Topics: Child; Genotype; Humans; Male; Obsessive-Compulsive Disorder; Polymorphism, Single Nucleotide; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline; Time Factors | 2014 |
Do antidepressant-induced manic episodes in obsessive-compulsive disorder patients represent the clinical expression of an underlying bipolarity?
Topics: Antidepressive Agents; Bipolar Disorder; Comorbidity; Female; Humans; Middle Aged; Obsessive-Compulsive Disorder; Sertraline | 2014 |
1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: effects of 12 weeks of sertraline treatment on brain metabolites.
Topics: Adult; Analysis of Variance; Aspartic Acid; Brain; Choline; Creatine; Female; Follow-Up Studies; Humans; Magnetic Resonance Spectroscopy; Male; Obsessive-Compulsive Disorder; Protons; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Young Adult | 2015 |
[Olfactory reference syndrome and hyperhidrosis: comorbidity in one patient].
Topics: Adult; Body Dysmorphic Disorders; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Drug Substitution; Halitosis; Hallucinations; Humans; Hyperhidrosis; Male; Models, Psychological; Obsessive-Compulsive Disorder; Psychotropic Drugs; Sertraline; Syndrome | 2014 |
Treatment of internet addiction in patient with panic disorder and obsessive compulsive disorder: a case report.
Topics: Behavior, Addictive; Clonazepam; Cognitive Behavioral Therapy; Female; Humans; Internet; Obsessive-Compulsive Disorder; Panic Disorder; Psychiatric Status Rating Scales; Psychotropic Drugs; Sertraline; Treatment Outcome; Young Adult | 2015 |
Serotonin syndrome precipitated by sertraline and discontinuation of clozapine.
Topics: Clozapine; Drug Administration Schedule; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Risk Factors; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Syndrome; Sertraline; Treatment Outcome | 2015 |
Topiramate augmentation in a patient with obsessive-compulsive disorder.
Topics: Adult; Anti-Anxiety Agents; Anticonvulsants; Citalopram; Drug Synergism; Fear; Female; Fructose; Humans; Lorazepam; Obsessive-Compulsive Disorder; Paroxetine; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Topiramate; Treatment Refusal | 2015 |
The girl who would not sit--case report.
Topics: Culture; Depressive Disorder; Ethnicity; Fear; Female; Housing; Humans; Obsessive-Compulsive Disorder; Psychotherapy; Sertraline; Social Isolation; Social Stigma; Social Values; United Kingdom; Young Adult | 2015 |
[The Usefulness of Clonazepam as an Augmentative Treatment in a Case of Severe Childhood Onset Obsessive-Compulsive Disorder].
Topics: Adolescent; Benzodiazepines; Clonazepam; Drug Therapy, Combination; Female; GABA Modulators; Humans; Obsessive-Compulsive Disorder; Olanzapine; Sertraline; Severity of Illness Index; Turkey | 2015 |
Recent NIMH clinical trials and implications for practice.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Child, Preschool; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Fluoxetine; Humans; Mental Disorders; Methylphenidate; Multicenter Studies as Topic; National Institute of Mental Health (U.S.); Obsessive-Compulsive Disorder; Psychotropic Drugs; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States; Venlafaxine Hydrochloride | 2008 |
Successful medication withdrawal after cognitive-behavioral therapy in a treatment-resistant preadolescent male with obsessive-compulsive disorder.
Topics: Adrenergic Uptake Inhibitors; Antipsychotic Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Drug Resistance; Drug Therapy, Combination; Follow-Up Studies; Humans; Male; Obsessive-Compulsive Disorder; Propylamines; Risperidone; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome | 2009 |
Hyperpigmentation with amisulpride.
Topics: Adult; Amisulpride; Antipsychotic Agents; Chronic Disease; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Hyperpigmentation; Obsessive-Compulsive Disorder; Photosensitivity Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline; Sulpiride | 2009 |
An uncontrollable gambling addiction.
Topics: Antidepressive Agents; Behavior, Addictive; Gambling; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Psychotherapy; Sertraline | 2008 |
Onychophagia as a spectrum of obsessive-compulsive disorder.
Topics: Adolescent; Adult; Clomipramine; Female; Humans; Nail Biting; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline | 2009 |
Diencephalic serotonin transporter availability predicts both transporter occupancy and treatment response to sertraline in obsessive-compulsive checkers.
Topics: Adult; Cocaine; Diencephalon; Drug Administration Routes; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Protein Binding; Radiopharmaceuticals; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline; Statistics as Topic; Tomography, Emission-Computed, Single-Photon; Young Adult | 2009 |
Sertraline-induced enuresis in a prepubertal child resolves after switching to fluoxetine.
Topics: Child; Enuresis; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline | 2010 |
Low serotonergic function and its normalization by treatment with sertraline in obsessive-compulsive disorder--an auditory evoked potential study.
Topics: Acoustic Stimulation; Adult; Auditory Cortex; Evoked Potentials, Auditory; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Serotonin; Sertraline; Treatment Outcome; Young Adult | 2010 |
[Torin (sertraline) in the treatment of depressive and obsessive-compulsive disorders in children].
Topics: Antidepressive Agents; Child; Depressive Disorder; Female; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline | 2010 |
Treatment practices in Tourette syndrome: the European perspective.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Depression; Europe; Fluoxetine; Fluvoxamine; Health Care Surveys; Humans; Methylphenidate; Obsessive-Compulsive Disorder; Physicians; Piperazines; Propylamines; Psychiatry; Quinolones; Risperidone; Sertraline; Sulpiride; Tourette Syndrome | 2012 |
[Treatment of comorbid obsessive-compulsive and depressive disorders in children age].
Topics: Adolescent; Antidepressive Agents; Child; Comorbidity; Depressive Disorder; Female; Humans; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Psychometrics; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2012 |
[Severe trichotillomania associated with obsessive ideation].
Topics: Adult; Antidepressive Agents; Cognitive Behavioral Therapy; Drug Therapy, Combination; Female; Humans; Obsessive-Compulsive Disorder; Sertraline; Severity of Illness Index; Treatment Outcome; Trichotillomania; Valproic Acid | 2012 |
Obsessive compulsive disorder in huntington disease: a case of isolated obsessions successfully treated with sertraline.
Topics: Adult; Female; Humans; Huntington Disease; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2002 |
Consultation with the specialist: the central serotonin syndrome: paradigm for psychotherapeutic misadventure.
Topics: Adolescent; Amphetamine-Related Disorders; Antidepressive Agents; Antitussive Agents; Anxiety Disorders; Child; Dextromethorphan; Diagnosis, Differential; Drug Interactions; Female; Fluvoxamine; Hallucinogens; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Obsessive-Compulsive Disorder; Seizures; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Serotonin Syndrome; Sertraline | 2002 |
Quetiapine augmentation of sertraline in obsessive-compulsive disorder.
Topics: Adult; Antipsychotic Agents; Dibenzothiazepines; Drug Therapy, Combination; Humans; Male; Obsessive-Compulsive Disorder; Personality Assessment; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
Olanzapine-sertraline combination in schizophrenia with obsessive-compulsive disorder.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Comorbidity; Drug Therapy, Combination; Humans; Middle Aged; Obsessive-Compulsive Disorder; Olanzapine; Pirenzepine; Schizophrenia, Paranoid; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2003 |
Early-onset obsessive-compulsive disorder.
Topics: Adolescent; Age Factors; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline | 2003 |
Brain reactivity to specific symptom provocation indicates prospective therapeutic outcome in OCD.
Topics: Adult; Arousal; Caudate Nucleus; Cerebral Cortex; Cues; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gyrus Cinguli; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Personality Inventory; Prognosis; Regional Blood Flow; Selective Serotonin Reuptake Inhibitors; Sertraline; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2003 |
Kinematical analysis of emotionally induced facial expressions in patients with obsessive-compulsive disorder.
Topics: Adult; Biomechanical Phenomena; Dose-Response Relationship, Drug; Drug Administration Schedule; Emotions; Facial Expression; Facial Muscles; Female; Humans; Laughter; Male; Middle Aged; Motion Pictures; Obsessive-Compulsive Disorder; Reaction Time; Reference Values; Selective Serotonin Reuptake Inhibitors; Sertraline; Wit and Humor as Topic | 2003 |
Fluvoxamine: new indication. No progress in obsessive-compulsive disorder.
Topics: Adolescent; Adult; Child; Drug Approval; Fluoxetine; France; Humans; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2004 |
Symptomatic depression after long-term steroid treatment: a case report.
Topics: Adult; Antidepressive Agents; Depression; Dose-Response Relationship, Drug; Glucocorticoids; Hepatitis C, Chronic; Humans; Male; Obsessive-Compulsive Disorder; Prednisone; Sertraline | 2004 |
Serotonin syndrome: a case report.
Topics: Child; Depressive Disorder; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sertraline | 2005 |
Epileptiform seizure after sertraline treatment in an adolescent experiencing obsessive-compulsive disorder and presenting a rare pharmacogenetic status.
Topics: Adolescent; Antipsychotic Agents; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Epilepsy; Female; Genotype; Humans; Isoenzymes; Obsessive-Compulsive Disorder; Pharmacogenetics; Phenotype; Selective Serotonin Reuptake Inhibitors; Sertraline | 2006 |
Bulimic forms of anorexia nervosa--case report no.1.
Topics: Adult; Anorexia Nervosa; Antidepressive Agents; Bulimia Nervosa; Female; Humans; Obsessive-Compulsive Disorder; Sertraline | 2003 |
Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder.
Topics: Acute Disease; Adolescent; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Tic Disorders; Tourette Syndrome | 2007 |
Punding as a complication of brain stem stroke?: report of a case.
Topics: Basilar Artery; Brain; Brain Stem; Brain Stem Infarctions; Cerebral Angiography; Dopamine; Dose-Response Relationship, Drug; Humans; Magnetic Resonance Imaging; Male; Mental Disorders; Middle Aged; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Stereotypic Movement Disorder; Treatment Outcome; Vertebrobasilar Insufficiency | 2007 |
Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive-compulsive disorder.
Topics: Adolescent; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Cognitive Behavioral Therapy; Combined Modality Therapy; Desensitization, Psychologic; Drug Therapy, Combination; Female; Humans; Male; Obsessive-Compulsive Disorder; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Sertraline | 2008 |
Trichotillomania and co-morbid psychiatric disorders in a 10-year-old boy.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Comorbidity; Drug Therapy, Combination; Fluoxetine; Humans; Male; Mental Status Schedule; Obsessive-Compulsive Disorder; Referral and Consultation; Sertraline; Tourette Syndrome; Trichotillomania | 2007 |
Priapism associated with sertraline.
Topics: Adolescent; Humans; Male; Obsessive-Compulsive Disorder; Priapism; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline | 2007 |
Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
Topics: Adult; Citalopram; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Demography; Drug Resistance; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Practice Guidelines as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Sertraline and tic: case report.
Topics: Adult; Depressive Disorder, Major; Eyelids; Female; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Stereotyped Behavior; Tics | 2007 |
Obsessive-compulsive disorder secondary to a right parietal lobe haemorrhage: a case report.
Topics: Adult; Cerebral Hemorrhage; Cerebrum; Headache; Humans; Magnetic Resonance Imaging; Male; Nausea; Obsessive-Compulsive Disorder; Parietal Lobe; Psychotherapy, Brief; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2007 |
Addition of trazodone to sertraline: a probable synergistic action in a case of obsessive-compulsive disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Drug Synergism; Drug Therapy, Combination; Female; Humans; Obsessive-Compulsive Disorder; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Sertraline; Trazodone | 2007 |
Psychopharmacology of pediatric obsessive-compulsive disorder: three case reports.
Topics: Antipsychotic Agents; Child, Preschool; Female; Humans; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Risperidone; Selective Serotonin Reuptake Inhibitors; Sertraline | 2008 |
[Psychopharmacological treatment and quality of life in obsessive compulsive disorder].
Topics: Adult; Female; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2008 |
One year follow-up of postpartum-onset obsessive-compulsive disorder: a case series.
Topics: Adult; Female; Follow-Up Studies; Humans; Obsessive-Compulsive Disorder; Postpartum Period; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline | 2008 |
Buspirone augmentation of sertraline.
Topics: 1-Naphthylamine; Adult; Anorexia Nervosa; Antidepressive Agents; Buspirone; Drug Therapy, Combination; Humans; Male; Obsessive-Compulsive Disorder; Sertraline | 1995 |
Valproate pretreatment for the difficult-to-treat patient with OCD.
Topics: 1-Naphthylamine; Antidepressive Agents; Clomipramine; Drug Therapy, Combination; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Paroxetine; Sertraline; Treatment Outcome; Valproic Acid | 1994 |
Treatment of clozapine-induced obsessive-compulsive symptoms with sertraline.
Topics: 1-Naphthylamine; Clozapine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Schizophrenia, Paranoid; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
Pharmacologic management of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Antidepressive Agents; Anxiety Disorders; Clomipramine; Depression; Dopamine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Synaptic Transmission; Trazodone | 1994 |
Panic attacks precipitated by sertraline.
Topics: 1-Naphthylamine; Adult; Humans; Male; Obsessive-Compulsive Disorder; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
Serotonin reuptake blockers for the treatment of obsessional jealousy.
Topics: 1-Naphthylamine; Adult; Clomipramine; Drug Therapy, Combination; Female; Fluoxetine; Humans; Jealousy; Male; Obsessive-Compulsive Disorder; Pimozide; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
Sertraline and mental retardation with obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Adult; Female; Humans; Intellectual Disability; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline | 1993 |
Sertraline in the treatment of neurotic excoriations and related disorders.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Depressive Disorder; Female; Humans; Male; Mental Disorders; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Skin Diseases | 1996 |
Medication optimization during clozapine treatment.
Topics: 1-Naphthylamine; Adult; Clozapine; Drug Therapy, Combination; Humans; Lithium; Male; Obsessive-Compulsive Disorder; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Valproic Acid | 1996 |
High doses of sertraline for treatment-resistant obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Will pindolol augment the response to a serotonin reuptake inhibitor in obsessive-compulsive disorder?
Topics: 1-Naphthylamine; Adrenergic beta-Antagonists; Adult; Antidepressive Agents; Clomipramine; Drug Synergism; Female; Fluoxetine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Pindolol; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Inability to cry during SRI treatment.
Topics: 1-Naphthylamine; Adult; Crying; Depressive Disorder; Emotions; Female; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors | 1996 |
Sertraline and akathisia: spontaneous resolution.
Topics: 1-Naphthylamine; Adult; Akathisia, Drug-Induced; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Neurologic Examination; Obsessive-Compulsive Disorder; Remission, Spontaneous; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
Treatment of risperidone-induced obsessive-compulsive symptoms with sertraline.
Topics: 1-Naphthylamine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Risperidone; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
Pica and the obsessive-compulsive spectrum disorders.
Topics: 1-Naphthylamine; Adolescent; Adult; Antidepressive Agents; Child; Citalopram; Clomipramine; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Pica; Sertraline; Tomography, Emission-Computed, Single-Photon | 1996 |
Differential response of psychotic and obsessive symptoms to risperidone in an adolescent.
Topics: 1-Naphthylamine; Adolescent; Antidepressive Agents; Antipsychotic Agents; Clomipramine; Hallucinations; Haloperidol; Humans; Male; Obsessive-Compulsive Disorder; Psychotic Disorders; Risperidone; Sertraline; Trifluoperazine | 1996 |
Behavioral therapy in children and adolescents with obsessive-compulsive disorder: a pilot study.
Topics: 1-Naphthylamine; Adolescent; Behavior Therapy; Child; Combined Modality Therapy; Female; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Pilot Projects; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Sertraline in the treatment of clozapine-induced obsessive-compulsive behavior.
Topics: Adult; Clozapine; Drug Therapy, Combination; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Schizophrenia, Paranoid; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Urinary retention with sertraline, haloperidol, and clonazepam combination.
Topics: Adult; Antipsychotic Agents; Clonazepam; Comorbidity; Constipation; Delusions; Drug Therapy, Combination; Female; GABA Modulators; Haloperidol; Humans; Obsessive-Compulsive Disorder; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Urinary Retention | 1998 |
Sertraline in the treatment of obsessive-compulsive disorder.
Topics: Antidepressive Agents; Controlled Clinical Trials as Topic; Humans; Multicenter Studies as Topic; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; United States; United States Food and Drug Administration | 1999 |
Serotonin syndrome in a child associated with erythromycin and sertraline.
Topics: Anti-Bacterial Agents; Child; Erythromycin; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sertraline | 1999 |
A possible tetracycline-risperidone-sertraline interaction in an adolescent.
Topics: Adolescent; Anti-Bacterial Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Drug Interactions; Drug Therapy, Combination; Humans; Male; Obsessive-Compulsive Disorder; Protein Synthesis Inhibitors; Risperidone; Sertraline; Tetracyclines; Tourette Syndrome | 1999 |
Effectiveness of olanzapine treatment for severe obsessive-compulsive disorder.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Olanzapine; Pirenzepine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1999 |
Lamotrigine augmentation of serotonin re-uptake inhibitors in obsessive-compulsive disorder.
Topics: Antidepressive Agents; Clomipramine; Dose-Response Relationship, Drug; Humans; Lamotrigine; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazines | 2000 |
Seizures associated with sertraline.
Topics: Adult; Female; Humans; Male; Obsessive-Compulsive Disorder; Seizures; Selective Serotonin Reuptake Inhibitors; Sertraline | 2000 |
Sertraline in the treatment of anxiety disorders.
Topics: Adult; Clinical Trials as Topic; Clomipramine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Obsessive-Compulsive Disorder; Panic Disorder; Phobic Disorders; Quality of Life; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Time Factors; Treatment Outcome | 2000 |
Sertraline and obsessive compulsive disorder: new indication. Limited assessment.
Topics: Adult; Clinical Trials as Topic; Clomipramine; Drug Approval; France; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2000 |
[Sertraline in child and adolescent psychiatry].
Topics: Adolescent; Anxiety Disorders; Child; Depressive Disorder; Drug Administration Schedule; Female; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Surveys and Questionnaires | 2001 |
Migraine and sertraline.
Topics: Child; Humans; Male; Migraine Disorders; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline | 2001 |
[The difference between obsessive-compulsive disorder in adolescence and in adults].
Topics: Adolescent; Adult; Female; Humans; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline | 2001 |
Extending indications for long-term pharmacotherapy: opportunities and challenges.
Topics: Bulimia; Chronic Disease; Fluoxetine; Humans; Long-Term Care; Obsessive-Compulsive Disorder; Sertraline | 2002 |
Treatment of late-onset OCD following basal ganglia infarct.
Topics: Aged; Basal Ganglia Cerebrovascular Disease; Cerebral Infarction; Cognitive Behavioral Therapy; Combined Modality Therapy; Desensitization, Psychologic; Drug Therapy, Combination; Humans; Lorazepam; Male; Obsessive-Compulsive Disorder; Sertraline; Treatment Outcome | 2002 |
Sertraline: new indication. May help children with obsessive-compulsive disorder.
Topics: Adolescent; Behavior Therapy; Child; Clomipramine; Drug Approval; France; Humans; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2002 |
Selective serotonin reuptake inhibitors in OCD.
Topics: 1-Naphthylamine; Clomipramine; Humans; Obsessive-Compulsive Disorder; Serotonin Antagonists; Sertraline | 1992 |